Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Wade Ackerman advises companies and trade associations on complex and novel FDA regulatory issues that require coordinated legal, regulatory, and public policy strategies. Through more than 16 years of experience in private practice and positions within the FDA and on Capitol Hill, Mr. Ackerman has acquired unique insights into the evolving legal and regulatory landscape facing companies marketing FDA-regulated products. He co-leads Covington’s multidisciplinary Digital Health Initiative, which brings together the firm’s considerable global resources to advise life sciences and technology clients harnessing the power of information technology and data to create new and cutting-edge innovations to improve health and achieve better outcomes for patients.

  • Advised global healthcare company GSK on FDA regulatory components of the company's $300 million equity investment and collaboration with genetic testing and data science company 23andMe -- a collaboration focused on R&D of new medicines, using human genetics as the basis for discovery.

Previous Experience

  • U.S. Senate Committee on Health, Education, Labor, and Pensions, Senior FDA Counsel
  • U.S. Food and Drug Administration, Associate Chief Counsel
  • Daily Journal, "Top Health Care Lawyers" (2020)
  • Named one of the most influential diverse lawyers in Los Angeles by the Los Angeles Business Journal (2018).
  • Legal 500 US, Health Care - Life Sciences (2017)